Development of TaqMan-based real-time RT-PCR assay based on N gene for the quantitative detection of feline

Siti Tasnim Makhtar1, Sheau Wei Tan2, Nur Amalina Nasruddin1

  • 1Faculty of Veterinary Medicine, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.

Abstract

Insights

A new TaqMan real-time RT-PCR assay effectively detects Feline morbillivirus (FeMV) in cats. This sensitive method improves early FeMV infection diagnosis compared to conventional RT-PCR.

Area of Science:

  • Veterinary Virology
  • Molecular Diagnostics
  • Feline Infectious Diseases

Background:

  • Morbilliviruses, including Feline morbillivirus (FeMV), are associated with significant animal diseases and economic losses.
  • FeMV is suspected to cause chronic kidney disease in cats, but its role remains unclear.
  • FeMV has a global distribution, detected across multiple continents.

Purpose of the Study:

  • To develop a sensitive TaqMan real-time RT-PCR (qRT-PCR) assay for detecting FeMV.
  • To target the N gene of FeMV for early infection detection in clinical samples.

Main Methods:

  • Development of a specific TaqMan real-time RT-PCR assay targeting the FeMV N gene.
  • Validation of the assay's specificity against related viruses (CDV, NDV, MeV) and other feline pathogens (FCoV, FeLV).
  • Determination of the assay's limit of detection and reproducibility (intra- and inter-assay variation).

Main Results:

  • The developed qRT-PCR assay demonstrated high specificity, with no cross-reactivity to other morbilliviruses or feline viruses.
  • The assay achieved a lower detection limit of 1.74 × 10^4 copies/μL.
  • Clinical sample testing revealed a significantly higher detection rate (35.2%) compared to conventional RT-PCR (15.5%), indicating enhanced sensitivity.

Conclusions:

  • The TaqMan-based real-time RT-PCR assay is a sensitive, specific, rapid, and reproducible tool for FeMV detection.
  • This assay facilitates the early diagnosis of FeMV infection in cats.
  • The improved diagnostic capability aids in understanding and managing FeMV-related health issues in feline populations.